Tweet by Carla Cobb, PharmD, BCPP 🏥👩‍⚕️😷 🇺🇸🇨🇦 on Twitter

nRcJ1HCj_normal.jpg spacer.png
Carla Cobb, PharmD, BCPP 🏥👩‍⚕️😷🇺🇸🇨🇦
⁦‪@PtCarePharm‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Excellent presentation by Dr. ⁦‪@thomasinselmd‬⁩ today at #CPNP2022 . We can improve outcomes for people with psychiatric disorders but it will take some uncomfortable changes. We need to hold providers accountable for evidence-based, high quality care. pic.twitter.com/uhGF21YGNh
4/25/22, 7:56 AM

Relish Life – ACEs based weight management proram

Begin forwarded message:

From: “Thornton,Joseph Edward” <joethornton@ufl.edu>
Date: April 19, 2022 at 9:35:31 AM HST
To: Joseph Thornton <josephthornton316@gmail.com>
Subject: Relish Life – ACEs based weight management proram



Bupropion and Naltrexone for Weight Loss | The Science | Relish Life

Joseph (Joe) E. Thornton, M.D., DFAPA
Adjunct Clinical Associate Professor, Psychiatry
University of Florida College of Medicine
joethornton@ufl.edu

CONFIDENTIALITY NOTIFICATION: Please be advised! This e-mail message, including any attachments, has been created explicitly for the sole use of the intended recipient(s) and may contain confidential and privileged information. The materials in this message are private and may contain Protected Healthcare Information or other information of a sensitive nature. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail. Any unauthorized review, use, disclosure, or distribution of such information is prohibited and will be upheld under the discretion of Federal and State law. If you have received this e-mail message in error and are not an intended recipient, please contact the sender via reply e-mail or phone and destroy all copies of the original message. Pursuant to ‘ FS 766.101, FS 395.0193, FS 395.0197, FS 766.1016 and other Statutes, this document is privileged and confidential. It is not subject to discovery. Please do NOT copy or release.

Tweet by Michael “Mike” Albert, MD on Twitter

kItBIxpz_normal.jpg spacer.png
Michael “Mike” Albert, MD
⁦‪@MichaelAlbertMD‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
We cannot make major improvements in the health of Americans until we provide scalable and effective solutions for our current weight epidemic. If you look at the scalable efficiency of certain interventions, medication is far and away the best prospect.
4/23/22, 11:48 PM

Tweet by Michael “Mike” Albert, MD on Twitter

kItBIxpz_normal.jpg spacer.png
Michael “Mike” Albert, MD
⁦‪@MichaelAlbertMD‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Remove your bias for a minute. Medication can reliably produce 15% weight loss and is a once a week injection. Unlike the barriers related to other interventions, medication is easier to maintain, more effective than diet and exercise, and now has minimal risk.
4/23/22, 11:48 PM

Tweet by Christina Mangurian, MD, MAS on Twitter

dY-DIeyB_normal.jpg spacer.png
Christina Mangurian, MD, MAS
⁦‪@CMangurian‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
What a pleasure to introduce ⁦‪@AlisonHwong‬⁩ at ⁦‪@UCSFPsychiatry‬⁩ grand rounds this past week! She gave a great talk about her research on premature mortality for people with SMI. If you missed it, you can see the talk below. ⁦‪@NCSP_UCSF‬⁩ ⁦‪@UCSF_IHPS‬⁩
youtube.com/watch?v=SRBXi1…
4/22/22, 6:18 PM

Telehealth physical exam and assessment for TD using the AIMS

Doctors Demonstrate How to Conduct a Telemedicine Exam (medscape.com)

11 minutes

Can the AIMS Exam Be Conducted Via Telepsychiatry? (hmpgloballearningnetwork.com)

brief

ClinicalThought

The Assessment of Tardive Dyskinesia Via Telepsychiatry

VIEW CLINICALTHOUGHT

VIEW MORE

Joseph (Joe) E. Thornton, M.D., DFAPA
Adjunct Clinical Associate Professor, Psychiatry
University of Florida College of Medicine
joethornton@ufl.edu

CONFIDENTIALITY NOTIFICATION: Please be advised! This e-mail message, including any attachments, has been created explicitly for the sole use of the intended recipient(s) and may contain confidential and privileged information. The materials in this message are private and may contain Protected Healthcare Information or other information of a sensitive nature. If you are not the intended recipient, be advised that any unauthorized use, disclosure, copying or the taking of any action in reliance on the contents of this information is strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail. Any unauthorized review, use, disclosure, or distribution of such information is prohibited and will be upheld under the discretion of Federal and State law. If you have received this e-mail message in error and are not an intended recipient, please contact the sender via reply e-mail or phone and destroy all copies of the original message. Pursuant to ‘ FS 766.101, FS 395.0193, FS 395.0197, FS 766.1016 and other Statutes, this document is privileged and confidential. It is not subject to discovery. Please do NOT copy or release.